rufinamide has been researched along with Adolescent Myoclonic Epilepsy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boor, R; Coppola, G; Dahlin, M; Kluger, G; Lotte, J; Mueller, A; Staudt, M; Striano, P; von Stuelpnagel, C | 1 |
1 other study(ies) available for rufinamide and Adolescent Myoclonic Epilepsy
Article | Year |
---|---|
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Longitudinal Studies; Male; Myoclonic Epilepsy, Juvenile; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Retrospective Studies; Seizures, Febrile; Sodium Channels; Treatment Outcome; Triazoles; Young Adult | 2011 |